Skip to main content

Table 1 Population characteristics

From: Correlation between PCT, 25(OH)D, PTX-3, AMS levels and the severity of diabetic ketoacidosis complicated by pancreatitis

Characteristics

DKA-AP

(n = 37)

DKA

(n = 161)

Control

(n = 72)

χ2/Z

P

Sex, n (%)

 Female

21 (56.76)

91 (56.52)

38 (52.78)

0.307

0.856

 Male

16 (43.24)

70 (43.48)

34 (47.22)

Age, year

63.29 ± 6.72

62.98 ± 7.01

64.01 ± 6.92

0.346

0.708

BMI, kg/m2

24.38 ± 3.01

24.19 ± 2.78

24.09 ± 2.68

0.267

0.766

Biochemical parameters

 Creatine, μmol/L

118.76 ± 18.73

117.98 ± 13.29

56.98 ± 6.93

391.612

< 0.001

 HbAlc, %

9.01 ± 2.02

8.91 ± 1.97

5.37 ± 0.76

110.988

< 0.001

 BUN, mmol/L

5.74 ± 0.34

5.43 ± 0.31

5.01 ± 0.28

130.692

< 0.001

 LDL, mmol/L

3.02 ± 0.76

2.99 ± 0.26

2.87 ± 0.27

1.431

0.241

 HDL, mmol/L

1.05 ± 0.21

0.92 ± 0.18

0.68 ± 0.23

76.904

< 0.001

 AST, U/L

56.83 ± 8.92

29.98 ± 2.19

28.08 ± 2.01

458.502

< 0.001

 ALT, U/L

63.19 ± 7.62

27.99 ± 2.23

27.23 ± 1.87

996.273

< 0.001

 CO2CP, mmol/L

30.08 ± 2.72

29.76 ± 1.08

28.08 ± 1.03

9.296

< 0.001

 Blood glucose, mol/L

13.02 ± 2.18

10.76 ± 1.92

5.36 ± 1.29

390.662

< 0.001

 Blood potassium, mmol/L

4.38 ± 0.28

4.26 ± 0.23

4.01 ± 0.19

53.713

< 0.001

 Blood sodium, mmol/L

147.93 ± 32.09

144.99 ± 31.29

142.97 ± 29.84

0.659

0.518

 Bloog ketone, M (P25, P75), mmol/L

4.83 (3.47, 6.03)

0.06 (0, 0.20)

0.03 (0, 0.18)

69.876

< 0.001

 hs-TnT, M (P25, P75), μg/L

0.08 (0.03, 0.019)

0.02 (0.02, 0.03)

0.01 (0, 0.14)

31.876

< 0.001

 BNP, ng/L

85.43 ± 6.38

67.98 ± 8.27

54.39 ± 5.83

616.474

< 0.001

 TG, mmol/L

2.73 ± 0.63

2.69 ± 0.59

2.51 ± 0.48

3.562

0.03

 TC, mmol/L

5.17 ± 0.47

4.82 ± 0.39

4.51 ± 0.23

66.639

< 0.001

 Lactate, M (P25, P75), mmol/L

2.71 (1.06, 4.73)

0.91 (0.51, 1.69)

0.89 (0.50, 1.61)

56.543

< 0.001

 pH

7.4 ± 0.26

7.1 ± 0.23

7.0 ± 0.09

84.499

< 0.001

 Frequency of diabetic ketoacidosis, M (P25, P75)

2 (1, 3)

0 (0, 1)

0

10.987

< 0.001

 Onset age of diabetes, M (P25, P75), year

35 (26, 58)

36 (28, 59)

0

−0.519

0.606

Type of diabetes, n (%)

 Type I

17

85

0

12.923

< 0.001

 Type II

19

41

0

 Unkown

1

35

0

Duration of diabetes, M (P25, P75), year

9 (0.6, 19)

0 (0, 1)

0

8.876

< 0.001

Complications, n (%)

 Vascular complications

17 (45.95)

31 (19.25)

0

11.671

0.001

 Abdominal pain

33 (81.08)

22 (13.66)

0

85.542

< 0.001

 Delirium

2 (5.41)

14 (8.70)

0

0.438

0.508

  1. ALT Alanine aminotransferase, AST Aspartate aminotransferase, BMI Body mass index, BNP Brain natriuretic peptide, BUN Blood urea nitrogen, CO2CP Carbondioxide combining power, HbAlc Hemoglobin A1C, HDL High density lipoprotein, hs-cTnT High sensitivity cardiac troponin testing, LDL Low density lipoprotein, TC Total cholesterol, TG Triacylglyceride